New report demonstrates the value of Scotland’s pharmaceutical industry, but ABPI warns against Scotland’s life science offering continues to provide high quality jobs, education and research and This report illustrates how vital our industry is to the economy…
Read MoreComment on this storyPfizer is reportedly working on a deal that could finally satisfy investors’ cravings for a big Last night, the Wall Street Journal reported that the pharma company is in very early talks to acquire Seagen…
Read MoreThe Association of the British Pharmaceutical Industry, the trade body for leading drugmakers, said the “excessive” UK medicines levy paid by drugmakers meant that Britain stood to lose in R&D investment over the next five the voluntary scheme…
Read MoreTBS Report 26 February, 2023, 10:50 am Last modified: 26 February, 2023, 03:21 pm The Dhaka Stock Exchange (DSE) has approved IBN Sina Pharmaceutical Industry Ltd’s application to change its name to “The IBN SINA Pharmaceutical Industry PLC” – an…
Read MoreA coalition of ethical investors have asked Johnson & Johnson, Merck, Pfizer, Eli Lilly, Gilead, Amgen, Regeneron, Bristol Myers Squibb and AbbVie to publish a report on the process they follow when applying for multiple patents on a single
Read MoreThe collaboration is part of VitaDAO’s latest fundraising disclosed in late January from strategic members, including Pfizer Ventures, Shine Capital and L1 Digital, among other longevity The million raised will be used to fund longevity research projects and…
Read MoreFrom the time the COVID-19 virus was sequenced to regulatory authorization of the first vaccine, 326 days This was a speed record for the pharmaceutical industry, but a group called the Coalition for Epidemic Preparedness Innovations (CEPI) argues that…
Read MoreMedicines for Europe, the organisation for generics and biosimilars, has called for the new law to encourage the uptake of generics and Credit: Panchenko Vladimir / The EU is planning a sweeping revision of its pharma legislation in…
Read MoreThe pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms, and the gravity of unmet needs, as well as the growing importance of technologies such as pharmacogenomics, digital therapeutics, and…
Read MoreThe opinions and forecasts expressed herein are solely those of Tom Lydon, and may not actually come to Information on this site should not be used or construed as an offer to sell, a solicitation of an offer to…
Read More
